Amitriptyline recalls
The FDA has published 3 recalls involving Amitriptyline since 2017. The latest was reported on 28 Feb 2018. Most were for potency & assay. C. O. Truxton has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 28 Feb 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 67%Class III 1 33%
Why amitriptyline is recalled
Companies
By year
All amitriptyline recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Amitriptyline HCl USP for prescription compounding recalled | American Pharmaceutical Ingredients | Potency & Assay | Nationwide |
| Drug | CLASS II | Amitriptyline HCL Tablets, USP 50 mg recalled by C. O. Truxton | C. O. Truxton | Labeling Errors | Nationwide |
| Drug | CLASS III | Amitriptyline HCl Tablets, USP 25 mg recalled by Sandoz IncorporatedAmitriptyline Hydrochloride | Sandoz Incorporated | Packaging Defects | Nationwide |
Should you stop taking Amitriptyline?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.